Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPX-351 followed by FLAG for Relapsed Pediatric AML
NCT02642965Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- May 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cytarabine in acute myeloid leukemia (AML), sponsored by Children's Oncology Group. Started May 2016; status: completed.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02642965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02642965.